Lisata Therapeutics Inc (LSTA)
3.60
+0.14
(+3.90%)
USD |
NASDAQ |
Jun 14, 16:00
3.60
0.00 (0.00%)
After-Hours: 20:00
Lisata Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2016 | 16.84% |
| December 31, 2015 | 18.22% |
| September 30, 2015 | 18.34% |
| June 30, 2015 | 1.16% |
| March 31, 2015 | -6.19% |
| December 31, 2014 | 21.10% |
| September 30, 2014 | 2.56% |
| June 30, 2014 | 18.08% |
| March 31, 2014 | 5.67% |
| December 31, 2013 | 18.00% |
| September 30, 2013 | 19.72% |
| June 30, 2013 | 2.85% |
| March 31, 2013 | 5.22% |
| December 31, 2012 | 8.77% |
| September 30, 2012 | 15.48% |
| June 30, 2012 | 18.86% |
| March 31, 2012 | 21.66% |
| December 31, 2011 | 21.42% |
| September 30, 2011 | 13.12% |
| June 30, 2011 | 19.00% |
| March 31, 2011 | 27.13% |
| December 31, 2010 | 19.07% |
| September 30, 2010 | 31.82% |
| June 30, 2010 | 33.47% |
| March 31, 2010 | 31.46% |
| Date | Value |
|---|---|
| December 31, 2009 | 15.73% |
| September 30, 2009 | 37.55% |
| June 30, 2009 | 50.16% |
| March 31, 2009 | 43.47% |
| December 31, 2008 | 43.55% |
| September 30, 2008 | 64.99% |
| June 30, 2008 | 83.39% |
| March 31, 2008 | |
| December 31, 2007 | 90.80% |
| September 30, 2007 | 46.05% |
| June 30, 2007 | 60.94% |
| March 31, 2007 | 97.76% |
| December 31, 2006 | 66.60% |
| September 30, 2006 | 28.66% |
| June 30, 2006 | 28.66% |
| March 31, 2006 | 28.66% |
| December 31, 2005 | 29.10% |
| September 30, 2005 | 30.03% |
| June 30, 2005 | 30.11% |
| March 31, 2005 | 29.60% |
| December 31, 2004 | 30.43% |
| September 30, 2004 | 33.83% |
| June 30, 2004 | 31.13% |
| March 31, 2004 | 29.51% |
| December 31, 2003 | 46.39% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Becton Dickinson & Co | 45.67% |
| Edwards Lifesciences Corp | 75.87% |
| AIM ImmunoTech Inc | 80.00% |
| Protalix BioTherapeutics Inc | 30.58% |
| Armata Pharmaceuticals Inc | -- |